Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia.

MLA

Zerbit, Jérémie, et al. “Asciminib and Ponatinib Combination in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.” Leukemia & Lymphoma, vol. 62, no. 14, Dec. 2021, pp. 3558–60. EBSCOhost, https://doi.org/10.1080/10428194.2021.1966787.

APA

Zerbit, J., Tamburini, J., Goldwirt, L., Decroocq, J., Cayuela, J. M., Chapuis, N., Contejean, A., Batista, R., Bouscary, D., & Willems, L. (2021). Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia & Lymphoma, 62(14), 3558–3560. https://doi.org/10.1080/10428194.2021.1966787

Chicago

Zerbit, Jérémie, Jerome Tamburini, Lauriane Goldwirt, Justine Decroocq, Jean Michel Cayuela, Nicolas Chapuis, Adrien Contejean, Rui Batista, Didier Bouscary, and Lise Willems. 2021. “Asciminib and Ponatinib Combination in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.” Leukemia & Lymphoma 62 (14): 3558–60. doi:10.1080/10428194.2021.1966787.